clinical trial
Natera Enrolls First Patients in HEROES Metastatic HER2+ Breast Cancer Trial
Natera's Signatera test and diagnostic imaging will be used to monitor patients for progression-free survival over the course of one year.
Biden Cancer Moonshot Announces New Initiatives to Improve Diagnosis, Precision Treatments
The program announced a series of new public and private initiatives and projects designed to support its stated goal of halving the cancer death rate over the next 25 years.
Canhelp Genomics Partners With Mirxes Singapore to Offer Tumor Origin Identification Testing
The firms will make the Canhelp-Origin tumor identification test available for patients with cancers of unknown origin in some Southeast Asian countries.
Sysmex Inostics Gets NYS CLEP Approval for Clinical Trial Use of Liquid Biopsy Assay
The Baltimore-based subsidiary of Japan's Sysmex said that the test is used to identify genetic mutations that are relevant for the treatment of various cancer types.
Exact Sciences Enrolls First Patient in Multi-Cancer Early Detection Study
Participants enrolled in the registry study will receive three years of MCED testing and two years of follow-on data collection.